Etnova Therapeutics Corp.
1 clinical trials · Sponsor
◉ Watch Etnova Therapeutics Corp.
| Record | Firm | Date |
|---|---|---|
| A Safety and Efficacy Study of Multiple Tyrosine Kinase Inhibitor Drug (ETN101) in Advanced Hepatocellular Carcinoma (NCT06326502) | Etnova Therapeutics Corp. | 2024-02-07 |
Track Etnova Therapeutics Corp. automatically
Every clearance here is in the API, with alerts when new ones post.